G
Genpharmasec
GENPHARMA Share Price
Commercial Services1.10
as on 13 Mar 2026 at 15:42
BSE
Market Cap
₹61 Cr
PE Ratio
-51.50
ROCE
3.30%
GENPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
61
PE Ratio
-51.50
PB Ratio
0.87
Dividend Yield
-
ROE
1.89%
ROCE
3.30%
Book Value (₹)
1.19
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 59.62% | 59.94% | 60.03% | 60.19% | 62.00% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GENPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Commercial Services
Sub Sector
Trading & Distributors
Company Classification
Microcap
BSE Scrip Code
531592
NSE Scrip Name
GENPHARMA
ISIN
INE861N01036



